A high dose of Novo Nordisk’s obesity drug Wegovy ... their weight, when looking at all participants regardless of how well they adhered to treatment. That compared with 15.6% weight loss ...
Novo Nordisk's high dose Wegovy (semaglutide) has shown improved weight loss while remaining safe and tolerable. In the Phase IIIb STEP UP trial, 7.2mg Wegovy demonstrated statistically ...
Novo Nordisk said that patients taking a higher dose of its blockbuster Wegovy obesity shot lost more weight than those on a lower dose without experiencing an increase in side effects ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback